General
Preferred name
SUCROSE
Synonyms
D-(+)-Saccharose ()
S-67F ()
NSC-406942 ()
GNE-410 ()
P&D ID
PD010332
CAS
57-50-1
100405-08-1
12040-73-2
25702-74-3
8027-47-2
4217-76-9
Tags
available
drug
natural product
Approved by
FDA
Drug indication
Discovery agent
Pain
Drug Status
approved
experimental
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
Sucrose (D-(+)-Saccharose) is a nonreducing disaccharide composed of glucose and fructose linked via their anomeric carbons.
DESCRIPTION
Sucrose is a disaccharide which is composed of glucose and fructose. Sucrose can be applied in some animal models, including metabolic disease, obesity, diet on preference, and diabetes, et al.
(Enamine Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
13
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NPC Screening Collection
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
77
Molecular Weight
342.12
Hydrogen Bond Acceptors
11
Hydrogen Bond Donors
8
Rotatable Bonds
5
Ring Count
2
Aromatic Ring Count
0
cLogP
-5.4
TPSA
189.53
Fraction CSP3
1.0
Chiral centers
9.0
Largest ring
6.0
QED
0.24
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
ACTA1, ATOX1, C22orf28, LYZ
Endogenous Metabolite
Pathway
Metabolic Enzyme/Protease
Source data

